Alumis grants CLO option on 186,200 shares

Alumis Inc. reported that Chief Legal Officer Sanam Pangali received a stock option grant for 186,200 shares of common stock at an exercise price of $26.31 per share on January 26, 2026.

Rhea-AI Filing Summary

Alumis Inc. reported that Chief Legal Officer Sanam Pangali received a stock option grant for 186,200 shares of common stock at an exercise price of $26.31 per share on January 26, 2026. These options give the right to buy Alumis shares at that price in the future.

According to the vesting terms, 25% of the shares underlying the option vest on January 26, 2027. The remaining shares then vest in equal monthly installments over the following 36 months, as long as the executive maintains Continuous Service under the company’s 2024 Equity Incentive Plan, with potential acceleration as provided in the plan.

Insider Trade Summary

Grant/Award: 186,200 shares

Grant/Award 1 txn

Insider Pangali Sanam

Role Chief Legal Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	186,200	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 186,200 contracts (Direct)

Footnotes (1)

1. F1. 25% of the shares underlying this option vest on January 26, 2027, and the remaining shares vest in equal monthly installments thereafter over the following 36 months, subject to acceleration and the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan) to the Issuer on each such vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Alumis (ALMS) report for Sanam Pangali?

Alumis reported a stock option grant to Chief Legal Officer Sanam Pangali. The award covers 186,200 shares of common stock at a $26.31 exercise price, reflecting equity-based compensation rather than a market purchase or sale of existing shares.

How many Alumis (ALMS) shares are covered by the new stock option?

The stock option grant covers 186,200 shares of Alumis common stock. This option gives the holder the right to buy those shares at a fixed $26.31 exercise price, subject to the vesting schedule and continued service conditions described in the grant.

What is the exercise price of the Alumis (ALMS) stock option granted?

The stock option granted has an exercise price of $26.31 per share. This means the holder can purchase Alumis common stock at that fixed price once portions of the option vest and become exercisable under the award’s vesting schedule.

What is the vesting schedule for the Alumis (ALMS) option grant?

Twenty-five percent of the shares underlying the option vest on January 26, 2027. The remaining shares then vest in equal monthly installments over the next 36 months, conditioned on the reporting person’s Continuous Service and any acceleration provisions in the 2024 Equity Incentive Plan.

Who received the Alumis (ALMS) stock option reported in this Form 4?

Chief Legal Officer Sanam Pangali received the reported stock option grant. The filing shows Pangali as an officer of Alumis and lists direct beneficial ownership of 186,200 derivative securities following the transaction, reflecting this newly granted option position.

Is the Alumis (ALMS) Form 4 transaction a purchase or a grant?

The transaction is reported with code “A,” indicating an award or grant of a stock option, not an open-market purchase. The option covers 186,200 shares at a $26.31 exercise price, with vesting tied to future service under Alumis’s 2024 Equity Incentive Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/28/2026 - 07:22 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pangali Sanam

(Last) (First) (Middle)

C/O ALUMIS INC.

280 EAST GRAND AVENUE

(Street)

SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ALUMIS INC. [ ALMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$26.31	01/26/2026		A		186,200		(1)	01/25/2036	Common Stock	186,200	$0	186,200	D

Explanation of Responses:

1. 25% of the shares underlying this option vest on January 26, 2027, and the remaining shares vest in equal monthly installments thereafter over the following 36 months, subject to acceleration and the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan) to the Issuer on each such vesting date.

	/s/ Sanam Pangali	01/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.